Header Logo

Connection

MILIND JAVLE to Subcutaneous Fat

Back to Details
This is a "connection" page, showing publications MILIND JAVLE has written about Subcutaneous Fat.
MILIND JAVLE
Connection Strength
0.038
Subcutaneous Fat
  1. Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer. Invest New Drugs. 2018 12; 36(6):1037-1043.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.